These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15733801)

  • 1. Re: Paroxetine in the treatment of severe non-dermatological pruritus.
    Hariharan B; Rajagopal MR
    J Pain Symptom Manage; 2005 Feb; 29(2):115; author reply 115-6. PubMed ID: 15733801
    [No Abstract]   [Full Text] [Related]  

  • 2. Paroxetine in the treatment of severe non-dermatological pruritus: a randomized, controlled trial.
    Zylicz Z; Krajnik M; Sorge AA; Costantini M
    J Pain Symptom Manage; 2003 Dec; 26(6):1105-12. PubMed ID: 14654262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paroxetine serum concentrations in depressed patients and response to treatment.
    Gilles M; Deuschle M; Kellner S; Shams M; Krumm B; Härtter S; Heuser I; Hiemke C
    Pharmacopsychiatry; 2005 May; 38(3):118-21. PubMed ID: 15902581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superiority of escitalopram to paroxetine in the treatment of depression.
    Kasper S; Baldwin DS; Larsson Lönn S; Boulenger JP
    Eur Neuropsychopharmacol; 2009 Apr; 19(4):229-37. PubMed ID: 19185467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paroxetine in a case of psychogenic pruritus and neurotic excoriations.
    Biondi M; Arcangeli T; Petrucci RM
    Psychother Psychosom; 2000; 69(3):165-6. PubMed ID: 10773782
    [No Abstract]   [Full Text] [Related]  

  • 6. Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.
    Blier P; Gobbi G; Turcotte JE; de Montigny C; Boucher N; Hébert C; Debonnel G
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):457-65. PubMed ID: 19345072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pruritus induced by interruption of paroxetine therapy.
    Mazzatenta C; Peonia G; Martini P
    Br J Dermatol; 2004 Apr; 150(4):787. PubMed ID: 15099390
    [No Abstract]   [Full Text] [Related]  

  • 8. What has dry cough in common with pruritus? Treatment of dry cough with paroxetine.
    Zylicz Z; Krajnik M
    J Pain Symptom Manage; 2004 Feb; 27(2):180-4. PubMed ID: 15157042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical picture and treatment of panic disorder accompanied with generalized anxiety].
    Reznik AM; Arbuzov AL; Khurbatova IG
    Voen Med Zh; 2007 Jan; 328(1):38-43. PubMed ID: 17436713
    [No Abstract]   [Full Text] [Related]  

  • 10. Redistribution of slow wave activity of sleep during pharmacological treatment of depression with paroxetine but not with nefazodone.
    Argyropoulos SV; Hicks JA; Nash JR; Bell CJ; Rich AS; Nutt DJ; Wilson S
    J Sleep Res; 2009 Sep; 18(3):342-8. PubMed ID: 19549078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resolution of sexual dysfunction during double-blind treatment of major depression with reboxetine or paroxetine.
    Baldwin D; Bridgman K; Buis C
    J Psychopharmacol; 2006 Jan; 20(1):91-6. PubMed ID: 16204325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy.
    Roscoe JA; Morrow GR; Hickok JT; Mustian KM; Griggs JJ; Matteson SE; Bushunow P; Qazi R; Smith B
    Breast Cancer Res Treat; 2005 Feb; 89(3):243-9. PubMed ID: 15754122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Hypericum extract WS 5570 and paroxetine in ongoing treatment after recovery from an episode of moderate to severe depression: results from a randomized multicenter study.
    Anghelescu IG; Kohnen R; Szegedi A; Klement S; Kieser M
    Pharmacopsychiatry; 2006 Nov; 39(6):213-9. PubMed ID: 17124643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of paroxetine in fatigue and depression of patients under chemotherapeutic treatment.
    Heras P; Kritikos K; Hatzopoulos A; Kritikos N; Heras V; Mitsibounas D
    Am J Ther; 2013; 20(3):254-6. PubMed ID: 19262364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression and psoriasis comorbidity. Treatment with paroxetine: two case reports.
    Luis Blay S
    Ann Clin Psychiatry; 2006; 18(4):271-2. PubMed ID: 17162628
    [No Abstract]   [Full Text] [Related]  

  • 16. Once-daily duloxetine 60 mg in the treatment of major depressive disorder: multicenter, double-blind, randomized, paroxetine-controlled, non-inferiority trial in China, Korea, Taiwan and Brazil.
    Lee P; Shu L; Xu X; Wang CY; Lee MS; Liu CY; Hong JP; Ruschel S; Raskin J; Colman SA; Harrison GA
    Psychiatry Clin Neurosci; 2007 Jun; 61(3):295-307. PubMed ID: 17472599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients.
    Boulenger JP; Huusom AK; Florea I; Baekdal T; Sarchiapone M
    Curr Med Res Opin; 2006 Jul; 22(7):1331-41. PubMed ID: 16834832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of affect incontinence with paroxetine].
    Erfurth A
    Psychiatr Prax; 1997 Jul; 24(4):208-9. PubMed ID: 9340665
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of paroxetine in treating major depressive disorder in persons with multiple sclerosis.
    Ehde DM; Kraft GH; Chwastiak L; Sullivan MD; Gibbons LE; Bombardier CH; Wadhwani R
    Gen Hosp Psychiatry; 2008; 30(1):40-8. PubMed ID: 18164939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time course of response to paroxetine: influence of plasma level.
    Gex-Fabry M; Gervasoni N; Eap CB; Aubry JM; Bondolfi G; Bertschy G
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):892-900. PubMed ID: 17395353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.